Keywords: Arena Phama, Lorcaserin, Lorquess, Obesity, Weight loss, Regulatory filings, EU, USA

Arena Pharma updates on lorcaserin filings in EU and USA

Article | 27 March 2012

San Diego, USA-based Arena Pharmaceuticals (Nasdaq: ARNA) revealed yesterday that the European Medicines Agency has accepted its Marketing Authorization Application ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Arena Pharmaceuticals

Go to company listing

Related Drugs

lorcaserin

Lorquess

Go to drug listing